DRREDDY:NSE
Dr Reddy's Laboratories Ltd
1 240,00 INR
arrow_upward
+0,86%(+10,60) 1 d.
13. 10., 15:30:00 GMT+5:30 · INR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre DRREDDY…
Otvoriť
1 230,90 INR
Vysoká
1 250,70 INR
Nízka
1 223,30 INR
Trh. kap.
1,03 bil.
Priem. obj.
1,82 mil.
Objem
2,42 mil.
Dividenda
0,65 %
Štvrťročná dividenda
2,00 INR
Prvý obchodný deň po vyplatení dividendy
10. 7. 2026
Pomer cena/zárobky
32,07
Max. za 52 týž.
1 414,90 INR
Min. za 52 týž.
1 101,00 INR
Výnosy na akciu
38,67 INR
Akcie v obehu
166,06 mil.
Počet zamestnancov
28 tis.
Otvoriť
1 230,90 INR
Vysoká
1 250,70 INR
Nízka
1 223,30 INR
Trh. kap.
1,03 bil.
Priem. obj.
1,82 mil.
Objem
2,42 mil.
Dividenda
0,65 %
Štvrťročná dividenda
2,00 INR
Prvý obchodný deň po vyplatení dividendy
10. 7. 2026
Pomer cena/zárobky
32,07
Max. za 52 týž.
1 414,90 INR
Min. za 52 týž.
1 101,00 INR
Výnosy na akciu
38,67 INR
Akcie v obehu
166,06 mil.
Počet zamestnancov
28 tis.
Súvisiace akcie
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
www.marketscreener.com
·
pred 18 hodinami
Dr. Reddy's Laboratories Shares Rise After BNP Paribas Upgrade
Profil
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology.
Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe.
By 2007, Dr. Wikipedia
Informácie o subjekte Dr Reddy's Laboratories Ltd
Generálny riaditeľErez Israeli
Zamestnanci27,5 tis.
Dátum založenia1984
Hlavné sídloHajdarabád, Andhrapradéš, India
Odvetvie-
Webdrreddys.com